CIENCIAS FARMACÉUTICAS
Departamento
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (107)
2024
-
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74
-
Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies
Bioorganic Chemistry, Vol. 146
-
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis
Gastroenterologia y Hepatologia, Vol. 47, Núm. 5, pp. 522-552
2023
-
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Medication delivery errors in outpatients with percutaneous endoscopic gastrostomy: effect on tube feeding replacement
Scientific Reports, Vol. 13, Núm. 1
-
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research, Vol. 194
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
-
Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution
Cancers, Vol. 15, Núm. 3
-
Validation and clinical evaluation of an ultra-performance liquid chromatography with ultraviolet detector method for plasma quantification of micafungin
Annals of Clinical Biochemistry, Vol. 60, Núm. 3, pp. 191-198
2022
-
External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia
British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1913-1924
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease
European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 222-227
-
Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients
Pharmaceutics, Vol. 14, Núm. 4
-
Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients
European Journal of Pharmaceutical Sciences, Vol. 168
-
Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
Frontiers in Immunology, Vol. 13
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
Autoimmune responses in oncology: Causes and significance
International Journal of Molecular Sciences, Vol. 22, Núm. 15
-
Comparison of ultra-performance liquid chromatography and ARK immunoassay for therapeutic drug monitoring of voriconazole
Annals of Clinical Biochemistry, Vol. 58, Núm. 6, pp. 657-660
-
Evaluation of current amikacin dosing recommendations and development of an interactive nomogram: The role of albumin
Pharmaceutics, Vol. 13, Núm. 2, pp. 1-13